Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphoedema: an underestimated health problem

Identifieur interne : 000655 ( PascalFrancis/Corpus ); précédent : 000654; suivant : 000656

Lymphoedema: an underestimated health problem

Auteurs : C. J. Moffatt ; P. J. Franks ; D. C. Doherty ; A. F. Williams ; C. Badger ; E. Jeffs ; N. Bosanquet ; P. S. Mortimer

Source :

RBID : Pascal:04-0089879

Descripteurs français

English descriptors

Abstract

Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 1460-2725
A03   1    @0 QJM : (Oxf., 1994, Print)
A05       @2 96
A06       @2 10
A08 01  1  ENG  @1 Lymphoedema: an underestimated health problem
A11 01  1    @1 MOFFATT (C. J.)
A11 02  1    @1 FRANKS (P. J.)
A11 03  1    @1 DOHERTY (D. C.)
A11 04  1    @1 WILLIAMS (A. F.)
A11 05  1    @1 BADGER (C.)
A11 06  1    @1 JEFFS (E.)
A11 07  1    @1 BOSANQUET (N.)
A11 08  1    @1 MORTIMER (P. S.)
A14 01      @1 Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University @2 London @3 GBR @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.
A14 02      @1 St George's Hospital Medical School @2 London @3 GBR @Z 5 aut. @Z 8 aut.
A14 03      @1 The Haven Trust @2 London @3 GBR @Z 6 aut.
A14 04      @1 Department of Bio-engineering, Imperial College @2 London @3 GBR @Z 7 aut.
A20       @1 731-738
A21       @1 2003
A23 01      @0 ENG
A43 01      @1 INIST @2 5050 @5 354000114843840040
A44       @0 0000 @1 © 2004 INIST-CNRS. All rights reserved.
A45       @0 21 ref.
A47 01  1    @0 04-0089879
A60       @1 P
A61       @0 A
A64 01  1    @0 QJM : (Oxford. 1994. Print)
A66 01      @0 GBR
C01 01    ENG  @0 Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.
C02 01  X    @0 002B12B06
C03 01  X  FRE  @0 Lymphoedème @5 01
C03 01  X  ENG  @0 Lymphedema @5 01
C03 01  X  SPA  @0 Linfedema @5 01
C03 02  X  FRE  @0 Homme @5 02
C03 02  X  ENG  @0 Human @5 02
C03 02  X  SPA  @0 Hombre @5 02
C03 03  X  FRE  @0 Royaume Uni @2 NG @5 03
C03 03  X  ENG  @0 United Kingdom @2 NG @5 03
C03 03  X  SPA  @0 Reino Unido @2 NG @5 03
C03 04  X  FRE  @0 Chronique @5 04
C03 04  X  ENG  @0 Chronic @5 04
C03 04  X  SPA  @0 Crónico @5 04
C03 05  X  FRE  @0 Evaluation @5 05
C03 05  X  ENG  @0 Evaluation @5 05
C03 05  X  SPA  @0 Evaluación @5 05
C03 06  X  FRE  @0 Soin @5 06
C03 06  X  ENG  @0 Care @5 06
C03 06  X  SPA  @0 Cuidado @5 06
C03 07  X  FRE  @0 Qualité vie @5 07
C03 07  X  ENG  @0 Quality of life @5 07
C03 07  X  SPA  @0 Calidad vida @5 07
C03 08  X  FRE  @0 Emploi @5 08
C03 08  X  ENG  @0 Employment @5 08
C03 08  X  SPA  @0 Empleo @5 08
C03 09  X  FRE  @0 Sexe @5 09
C03 09  X  ENG  @0 Sex @5 09
C03 09  X  SPA  @0 Sexo @5 09
C03 10  X  FRE  @0 Age @5 10
C03 10  X  ENG  @0 Age @5 10
C03 10  X  SPA  @0 Edad @5 10
C03 11  X  FRE  @0 Santé publique @5 11
C03 11  X  ENG  @0 Public health @5 11
C03 11  X  SPA  @0 Salud pública @5 11
C03 12  X  FRE  @0 Epidémiologie @5 12
C03 12  X  ENG  @0 Epidemiology @5 12
C03 12  X  SPA  @0 Epidemiología @5 12
C03 13  X  FRE  @0 Traitement @5 13
C03 13  X  ENG  @0 Treatment @5 13
C03 13  X  SPA  @0 Tratamiento @5 13
C03 14  X  FRE  @0 Enquête @5 18
C03 14  X  ENG  @0 Survey @5 18
C03 14  X  SPA  @0 Encuesta @5 18
C03 15  X  FRE  @0 Questionnaire @5 19
C03 15  X  ENG  @0 Questionnaire @5 19
C03 15  X  SPA  @0 Cuestionario @5 19
C03 16  X  FRE  @0 Service santé @5 20
C03 16  X  ENG  @0 Health service @5 20
C03 16  X  SPA  @0 Servicio sanidad @5 20
C03 17  X  FRE  @0 Personnel sanitaire @5 21
C03 17  X  ENG  @0 Health staff @5 21
C03 17  X  SPA  @0 Personal sanitario @5 21
C03 18  X  FRE  @0 Utilisateur @5 22
C03 18  X  ENG  @0 User @5 22
C03 18  X  SPA  @0 Usuario @5 22
C03 19  X  FRE  @0 Morbidité @5 23
C03 19  X  ENG  @0 Morbidity @5 23
C03 19  X  SPA  @0 Morbilidad @5 23
C07 01  X  FRE  @0 Europe @2 NG
C07 01  X  ENG  @0 Europe @2 NG
C07 01  X  SPA  @0 Europa @2 NG
C07 02  X  FRE  @0 Appareil circulatoire pathologie @5 37
C07 02  X  ENG  @0 Cardiovascular disease @5 37
C07 02  X  SPA  @0 Aparato circulatorio patología @5 37
C07 03  X  FRE  @0 Lymphatique pathologie @5 38
C07 03  X  ENG  @0 Lymphatic vessel disease @5 38
C07 03  X  SPA  @0 Linfático patología @5 38
N21       @1 061
N82       @1 PSI

Format Inist (serveur)

NO : PASCAL 04-0089879 INIST
ET : Lymphoedema: an underestimated health problem
AU : MOFFATT (C. J.); FRANKS (P. J.); DOHERTY (D. C.); WILLIAMS (A. F.); BADGER (C.); JEFFS (E.); BOSANQUET (N.); MORTIMER (P. S.)
AF : Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University/London/Royaume-Uni (1 aut., 2 aut., 3 aut., 4 aut.); St George's Hospital Medical School/London/Royaume-Uni (5 aut., 8 aut.); The Haven Trust/London/Royaume-Uni (6 aut.); Department of Bio-engineering, Imperial College/London/Royaume-Uni (7 aut.)
DT : Publication en série; Niveau analytique
SO : QJM : (Oxford. 1994. Print); ISSN 1460-2725; Royaume-Uni; Da. 2003; Vol. 96; No. 10; Pp. 731-738; Bibl. 21 ref.
LA : Anglais
EA : Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.
CC : 002B12B06
FD : Lymphoedème; Homme; Royaume Uni; Chronique; Evaluation; Soin; Qualité vie; Emploi; Sexe; Age; Santé publique; Epidémiologie; Traitement; Enquête; Questionnaire; Service santé; Personnel sanitaire; Utilisateur; Morbidité
FG : Europe; Appareil circulatoire pathologie; Lymphatique pathologie
ED : Lymphedema; Human; United Kingdom; Chronic; Evaluation; Care; Quality of life; Employment; Sex; Age; Public health; Epidemiology; Treatment; Survey; Questionnaire; Health service; Health staff; User; Morbidity
EG : Europe; Cardiovascular disease; Lymphatic vessel disease
SD : Linfedema; Hombre; Reino Unido; Crónico; Evaluación; Cuidado; Calidad vida; Empleo; Sexo; Edad; Salud pública; Epidemiología; Tratamiento; Encuesta; Cuestionario; Servicio sanidad; Personal sanitario; Usuario; Morbilidad
LO : INIST-5050.354000114843840040
ID : 04-0089879

Links to Exploration step

Pascal:04-0089879

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Lymphoedema: an underestimated health problem</title>
<author>
<name sortKey="Moffatt, C J" sort="Moffatt, C J" uniqKey="Moffatt C" first="C. J." last="Moffatt">C. J. Moffatt</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Franks, P J" sort="Franks, P J" uniqKey="Franks P" first="P. J." last="Franks">P. J. Franks</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Doherty, D C" sort="Doherty, D C" uniqKey="Doherty D" first="D. C." last="Doherty">D. C. Doherty</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Williams, A F" sort="Williams, A F" uniqKey="Williams A" first="A. F." last="Williams">A. F. Williams</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Badger, C" sort="Badger, C" uniqKey="Badger C" first="C." last="Badger">C. Badger</name>
<affiliation>
<inist:fA14 i1="02">
<s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E." last="Jeffs">E. Jeffs</name>
<affiliation>
<inist:fA14 i1="03">
<s1>The Haven Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bosanquet, N" sort="Bosanquet, N" uniqKey="Bosanquet N" first="N." last="Bosanquet">N. Bosanquet</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Bio-engineering, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mortimer, P S" sort="Mortimer, P S" uniqKey="Mortimer P" first="P. S." last="Mortimer">P. S. Mortimer</name>
<affiliation>
<inist:fA14 i1="02">
<s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">04-0089879</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0089879 INIST</idno>
<idno type="RBID">Pascal:04-0089879</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000655</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Lymphoedema: an underestimated health problem</title>
<author>
<name sortKey="Moffatt, C J" sort="Moffatt, C J" uniqKey="Moffatt C" first="C. J." last="Moffatt">C. J. Moffatt</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Franks, P J" sort="Franks, P J" uniqKey="Franks P" first="P. J." last="Franks">P. J. Franks</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Doherty, D C" sort="Doherty, D C" uniqKey="Doherty D" first="D. C." last="Doherty">D. C. Doherty</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Williams, A F" sort="Williams, A F" uniqKey="Williams A" first="A. F." last="Williams">A. F. Williams</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Badger, C" sort="Badger, C" uniqKey="Badger C" first="C." last="Badger">C. Badger</name>
<affiliation>
<inist:fA14 i1="02">
<s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E." last="Jeffs">E. Jeffs</name>
<affiliation>
<inist:fA14 i1="03">
<s1>The Haven Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bosanquet, N" sort="Bosanquet, N" uniqKey="Bosanquet N" first="N." last="Bosanquet">N. Bosanquet</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Bio-engineering, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mortimer, P S" sort="Mortimer, P S" uniqKey="Mortimer P" first="P. S." last="Mortimer">P. S. Mortimer</name>
<affiliation>
<inist:fA14 i1="02">
<s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">QJM : (Oxford. 1994. Print)</title>
<title level="j" type="abbreviated">QJM : (Oxf., 1994, Print)</title>
<idno type="ISSN">1460-2725</idno>
<imprint>
<date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">QJM : (Oxford. 1994. Print)</title>
<title level="j" type="abbreviated">QJM : (Oxf., 1994, Print)</title>
<idno type="ISSN">1460-2725</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age</term>
<term>Care</term>
<term>Chronic</term>
<term>Employment</term>
<term>Epidemiology</term>
<term>Evaluation</term>
<term>Health service</term>
<term>Health staff</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Morbidity</term>
<term>Public health</term>
<term>Quality of life</term>
<term>Questionnaire</term>
<term>Sex</term>
<term>Survey</term>
<term>Treatment</term>
<term>United Kingdom</term>
<term>User</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Lymphoedème</term>
<term>Homme</term>
<term>Royaume Uni</term>
<term>Chronique</term>
<term>Evaluation</term>
<term>Soin</term>
<term>Qualité vie</term>
<term>Emploi</term>
<term>Sexe</term>
<term>Age</term>
<term>Santé publique</term>
<term>Epidémiologie</term>
<term>Traitement</term>
<term>Enquête</term>
<term>Questionnaire</term>
<term>Service santé</term>
<term>Personnel sanitaire</term>
<term>Utilisateur</term>
<term>Morbidité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1460-2725</s0>
</fA01>
<fA03 i2="1">
<s0>QJM : (Oxf., 1994, Print)</s0>
</fA03>
<fA05>
<s2>96</s2>
</fA05>
<fA06>
<s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Lymphoedema: an underestimated health problem</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MOFFATT (C. J.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>FRANKS (P. J.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>DOHERTY (D. C.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>WILLIAMS (A. F.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BADGER (C.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>JEFFS (E.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BOSANQUET (N.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>MORTIMER (P. S.)</s1>
</fA11>
<fA14 i1="01">
<s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>The Haven Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Bio-engineering, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>731-738</s1>
</fA20>
<fA21>
<s1>2003</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>5050</s2>
<s5>354000114843840040</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>21 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>04-0089879</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>QJM : (Oxford. 1994. Print)</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B12B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Royaume Uni</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>United Kingdom</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Reino Unido</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Chronique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Chronic</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Crónico</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Evaluation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Evaluation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Evaluación</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Soin</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Care</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Cuidado</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Qualité vie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Quality of life</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Calidad vida</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Emploi</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Employment</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Empleo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Sexe</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Sex</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Sexo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Age</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Age</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Edad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Santé publique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Public health</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Salud pública</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Epidémiologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Epidemiology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Epidemiología</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Enquête</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Survey</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Encuesta</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Questionnaire</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG">
<s0>Questionnaire</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA">
<s0>Cuestionario</s0>
<s5>19</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE">
<s0>Service santé</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG">
<s0>Health service</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA">
<s0>Servicio sanidad</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE">
<s0>Personnel sanitaire</s0>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG">
<s0>Health staff</s0>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA">
<s0>Personal sanitario</s0>
<s5>21</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE">
<s0>Utilisateur</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG">
<s0>User</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA">
<s0>Usuario</s0>
<s5>22</s5>
</fC03>
<fC03 i1="19" i2="X" l="FRE">
<s0>Morbidité</s0>
<s5>23</s5>
</fC03>
<fC03 i1="19" i2="X" l="ENG">
<s0>Morbidity</s0>
<s5>23</s5>
</fC03>
<fC03 i1="19" i2="X" l="SPA">
<s0>Morbilidad</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Europa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Lymphatique pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>061</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 04-0089879 INIST</NO>
<ET>Lymphoedema: an underestimated health problem</ET>
<AU>MOFFATT (C. J.); FRANKS (P. J.); DOHERTY (D. C.); WILLIAMS (A. F.); BADGER (C.); JEFFS (E.); BOSANQUET (N.); MORTIMER (P. S.)</AU>
<AF>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University/London/Royaume-Uni (1 aut., 2 aut., 3 aut., 4 aut.); St George's Hospital Medical School/London/Royaume-Uni (5 aut., 8 aut.); The Haven Trust/London/Royaume-Uni (6 aut.); Department of Bio-engineering, Imperial College/London/Royaume-Uni (7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>QJM : (Oxford. 1994. Print); ISSN 1460-2725; Royaume-Uni; Da. 2003; Vol. 96; No. 10; Pp. 731-738; Bibl. 21 ref.</SO>
<LA>Anglais</LA>
<EA>Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.</EA>
<CC>002B12B06</CC>
<FD>Lymphoedème; Homme; Royaume Uni; Chronique; Evaluation; Soin; Qualité vie; Emploi; Sexe; Age; Santé publique; Epidémiologie; Traitement; Enquête; Questionnaire; Service santé; Personnel sanitaire; Utilisateur; Morbidité</FD>
<FG>Europe; Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Lymphedema; Human; United Kingdom; Chronic; Evaluation; Care; Quality of life; Employment; Sex; Age; Public health; Epidemiology; Treatment; Survey; Questionnaire; Health service; Health staff; User; Morbidity</ED>
<EG>Europe; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Linfedema; Hombre; Reino Unido; Crónico; Evaluación; Cuidado; Calidad vida; Empleo; Sexo; Edad; Salud pública; Epidemiología; Tratamiento; Encuesta; Cuestionario; Servicio sanidad; Personal sanitario; Usuario; Morbilidad</SD>
<LO>INIST-5050.354000114843840040</LO>
<ID>04-0089879</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000655 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000655 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:04-0089879
   |texte=   Lymphoedema: an underestimated health problem
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024